Analysis of the profile of immune cells, cytokines and chemokines in previously untreated patients with hemophilia

被引：0
|
作者：
Jardim, L. [1 ]
Chaves, D. G. [2 ]
Cerqueira, M. H. [3 ]
Prezoti, A. [4 ]
Lorenzato, C. S. [5 ]
Portugal, M. S. [6 ]
Rezende, S. M. [1 ]
机构：
[1] Univ Fed Minas Gerais, Fac Med, Med Clin, Belo Horizonte, MG, Brazil
[2] Hemominas, Pesquisa, Belo Horizonte, MG, Brazil
[3] Hemorio, Rio De Janeiro, Brazil
[4] Hemoes, Vitoria, Brazil
[5] Hemepar, Curitiba, Parana, Brazil
[6] Hemominas, Belo Horizonte, MG, Brazil
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO034-WED
引用
收藏
页码：766 / 766
页数：1
相关论文
共 50 条
  • [21] High throughput analysis of antibody binding profiles in previously untreated severe hemophilia A
    Palla, R.
    HAEMOPHILIA, 2019, 25 : 23 - 24
  • [22] Use of Immune Cells, Cytokines and Chemokines as Biomarkers after Kidney Transplantation
    Blume, C. A.
    Daemmrich, M.
    Falk, C. S.
    TRANSPLANTATION, 2012, 94 (10) : 874 - 874
  • [23] French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII:: Incidence of inhibitor and evaluation of immune tolerance
    Rothschild, C
    Laurian, Y
    Satre, EP
    Derlon, AB
    Chambost, H
    Moreau, P
    Goudemand, J
    Parquet, A
    Peynet, J
    Vicariot, M
    Beurrier, P
    Claeyssens, S
    Durin, A
    Faradji, A
    Fressinaud, E
    Gaillard, S
    Guérin, V
    Guérois, C
    Pernod, G
    Pouzol, P
    Schved, JF
    Gazengel, C
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (05) : 779 - 783
  • [24] Expression profile and kinetics of cytokines and chemokines in patients with chronic hepatitis C
    Han, Zhen-Qi
    Huang, Tao
    Deng, Yong-Zhi
    Zhu, Guang-Ze
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10): : 17995 - 18003
  • [25] Profile of cytokines and chemokines in peripheral blood in Colombian patients with lupus nephritis
    Pacheco, L.
    Navarro-Quiroz, E. A.
    Diaz, Y.
    Almendral, L.
    Gonzalez-Torres, H. J.
    Bermejo, E. Egea
    Iglesias Gamarra, A.
    Aroca Martinez, G. J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (03) : S23 - S23
  • [26] Tailoring hemostatic therapies to lower inhibitor development in previously untreated patients with severe hemophilia A
    Mannucci, P. M.
    Mancuso, M. E.
    Franchini, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (07) : 1330 - 1336
  • [27] Clinical Evaluation of a Recombinant Factor VIII Preparation (Kogenate) in Previously Untreated Patients with Hemophilia A
    A. Yoshioka
    K. Fukutake
    J. Takamatsu
    A. Shirahata
    International Journal of Hematology, 2003, 78 : 467 - 474
  • [28] Validation of the prediction score for inhibitor development in previously untreated patients (PUPs) with severe hemophilia A
    Hashemi, S.
    Fischer, K.
    Van den Berg, H.
    HAEMOPHILIA, 2012, 18 : 89 - 89
  • [29] Comparison of high responder inhibitor frequency in recent studies of previously untreated patients with hemophilia A
    Ehrlich, HJ
    Bray, GL
    Gomperts, ED
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (01) : 242 - 243
  • [30] Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A
    van den Berg, H. Marijke
    Fischer, Kathelijn
    Carcao, Manuel
    Chambost, Herve
    Kenet, Gili
    Kurnik, Karin
    Konigs, Chris
    Male, Christoph
    Santagostino, Elena
    Ljung, Rolf
    BLOOD, 2019, 134 (03) : 317 - 320
12345